205 related articles for article (PubMed ID: 30348808)
21. MicroRNA-22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma.
Zhang S; Zhang D; Yi C; Wang Y; Wang H; Wang J
Oncol Rep; 2016 Jan; 35(1):559-67. PubMed ID: 26499759
[TBL] [Abstract][Full Text] [Related]
22. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
Wu D; Pan H; Zhou Y; Zhou J; Fan Y; Qu P
Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
Li G; Chong T; Xiang X; Yang J; Li H
Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
[TBL] [Abstract][Full Text] [Related]
24. MiR-186 represses progression of renal cell cancer by directly targeting CDK6.
Guo Z; Lv X; Jia H
Hum Cell; 2020 Jul; 33(3):759-767. PubMed ID: 32266659
[TBL] [Abstract][Full Text] [Related]
25. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
Liu F; Chen N; Xiao R; Wang W; Pan Z
Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
[TBL] [Abstract][Full Text] [Related]
26. MiR-373 promotes proliferation and metastasis of oral squamous cell carcinoma by targeting SPOP.
Zhang XJ; Jin Y; Song JL; Deng F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5270-5276. PubMed ID: 31298378
[TBL] [Abstract][Full Text] [Related]
27. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
Sekino Y; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
[TBL] [Abstract][Full Text] [Related]
29. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A
PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447
[TBL] [Abstract][Full Text] [Related]
30. Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma.
Chen Z; Li Z; Li C; Li B; Wang H; Nong D; Li X; Huang G; Lin J; Li W
BMC Cancer; 2022 Dec; 22(1):1277. PubMed ID: 36474188
[TBL] [Abstract][Full Text] [Related]
31. LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG.
Pu Y; Dong Z; Xia Y; Zhang M; Song J; Han J; Liu H
Biomed Pharmacother; 2019 Oct; 118():109382. PubMed ID: 31545257
[TBL] [Abstract][Full Text] [Related]
32. MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5.
Pan YJ; Wei LL; Wu XJ; Huo FC; Mou J; Pei DS
Cell Death Dis; 2017 Oct; 8(10):e3155. PubMed ID: 29072688
[TBL] [Abstract][Full Text] [Related]
33. miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.
Peng H; Wang X; Zhang P; Sun T; Ren X; Xia Z
Int J Clin Exp Pathol; 2015; 8(2):2259-66. PubMed ID: 25973137
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-induced lncHILAR promotes renal cancer metastasis via ceRNA for the miR-613/206/ 1-1-3p/Jagged-1/Notch/CXCR4 signaling pathway.
Hu G; Ma J; Zhang J; Chen Y; Liu H; Huang Y; Zheng J; Xu Y; Xue W; Zhai W
Mol Ther; 2021 Oct; 29(10):2979-2994. PubMed ID: 34058384
[TBL] [Abstract][Full Text] [Related]
35. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
[TBL] [Abstract][Full Text] [Related]
36. MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
Qin Z; Wei X; Jin N; Wang Y; Zhao R; Hu Y; Yan W; Li J; Zhou Q
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1920-1925. PubMed ID: 29130345
[TBL] [Abstract][Full Text] [Related]
37. miR-206 inhibits renal cell cancer growth by targeting GAK.
Wei C; Wang S; Ye ZQ; Chen ZQ
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
[TBL] [Abstract][Full Text] [Related]
38. Differentially expressed microRNA-218 modulates the viability of renal cell carcinoma by regulating BCL9.
Wang J; Ying Y; Bo S; Li G; Yuan F
Mol Med Rep; 2016 Aug; 14(2):1829-34. PubMed ID: 27314976
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
[TBL] [Abstract][Full Text] [Related]
40. lncRNA ROR promotes the progression of renal cell carcinoma through the miR‑206/VEGF axis.
Shi J; Zhang D; Zhong Z; Zhang W
Mol Med Rep; 2019 Oct; 20(4):3782-3792. PubMed ID: 31485634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
